The FDA has allowed stem cell testing: details
The damaged areas of the spinal cord of patients will be injected not with embryonic stem cells themselves, but with the progenitor cells of oligodendrocytes derived from them, responsible for the formation of the myelin sheath of neurons. It is assumed that an increase in the number of these cells will create favorable conditions for the regeneration of damaged nerve fibers.
26.01.2009